BACKGROUND: The efficacy of ablative surgery for head and neck squamous cell carcinoma (HNSCC) depends critically on obtaining negative margins. Although intraoperative "frozen section" analysis of margins is a valuable adjunct, it is expensive, time-consuming, and highly dependent on pathologist expertise. Optical imaging has potential to improve the accuracy of margins by identifying cancerous tissue in real time. Our goal was to determine the accuracy and inter-rater reliability of head and neck cancer specialists using high-resolution microendoscopic (HRME) images to discriminate between cancerous and benign mucosa. METHODS: Thirty-eight patients diagnosed with head and neck squamous cell carcinoma (HNSCC) were enrolled in this single-center study. HRME was used to image each specimen after application of proflavine, with concurrent standard histopathologic analysis. Images were evaluated for quality control, and a training set containing representative images of benign and neoplastic tissue was assembled. After viewing training images, seven head and neck cancer specialists with no previous HRME experience reviewed 36 test images and were asked to classify each. RESULTS: The mean accuracy of all reviewers in correctly diagnosing neoplastic mucosa was 97% (95% confidence interval (CI), 94-99%). The mean sensitivity and specificity were 98% (97-100%) and 92% (87-98%), respectively. The Fleiss kappa statistic for inter-rater reliability was 0.84 (0.77-0.91). CONCLUSIONS: Medical professionals can be quickly trained to use HRME to discriminate between benign and neoplastic mucosa in the head and neck. With further development, the HRME shows promise as a method of real-time margin determination at the point of care.
BACKGROUND: The efficacy of ablative surgery for head and neck squamous cell carcinoma (HNSCC) depends critically on obtaining negative margins. Although intraoperative "frozen section" analysis of margins is a valuable adjunct, it is expensive, time-consuming, and highly dependent on pathologist expertise. Optical imaging has potential to improve the accuracy of margins by identifying cancerous tissue in real time. Our goal was to determine the accuracy and inter-rater reliability of head and neck cancer specialists using high-resolution microendoscopic (HRME) images to discriminate between cancerous and benign mucosa. METHODS: Thirty-eight patients diagnosed with head and neck squamous cell carcinoma (HNSCC) were enrolled in this single-center study. HRME was used to image each specimen after application of proflavine, with concurrent standard histopathologic analysis. Images were evaluated for quality control, and a training set containing representative images of benign and neoplastic tissue was assembled. After viewing training images, seven head and neck cancer specialists with no previous HRME experience reviewed 36 test images and were asked to classify each. RESULTS: The mean accuracy of all reviewers in correctly diagnosing neoplastic mucosa was 97% (95% confidence interval (CI), 94-99%). The mean sensitivity and specificity were 98% (97-100%) and 92% (87-98%), respectively. The Fleiss kappa statistic for inter-rater reliability was 0.84 (0.77-0.91). CONCLUSIONS: Medical professionals can be quickly trained to use HRME to discriminate between benign and neoplastic mucosa in the head and neck. With further development, the HRME shows promise as a method of real-time margin determination at the point of care.
Authors: Richard A Schwarz; Wen Gao; Dania Daye; Michelle D Williams; Rebecca Richards-Kortum; Ann M Gillenwater Journal: Appl Opt Date: 2008-02-20 Impact factor: 1.980
Authors: Shi Ke; Xiaoxia Wen; Michael Gurfinkel; Chusilp Charnsangavej; Sidney Wallace; Eva M Sevick-Muraca; Chun Li Journal: Cancer Res Date: 2003-11-15 Impact factor: 12.701
Authors: N Ramanujam; M F Mitchell; A Mahadevan; S Warren; S Thomsen; E Silva; R Richards-Kortum Journal: Proc Natl Acad Sci U S A Date: 1994-10-11 Impact factor: 11.205
Authors: Ralf Kiesslich; Juergen Burg; Michael Vieth; Janina Gnaendiger; Meike Enders; Peter Delaney; Adrian Polglase; Wendy McLaren; Daniela Janell; Steven Thomas; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Gastroenterology Date: 2004-09 Impact factor: 22.682
Authors: Froukje L J Cals; Tom C Bakker Schut; José A Hardillo; Robert J Baatenburg de Jong; Senada Koljenović; Gerwin J Puppels Journal: Lab Invest Date: 2015-08-03 Impact factor: 5.662
Authors: Guolan Lu; James V Little; Xu Wang; Hongzheng Zhang; Mihir R Patel; Christopher C Griffith; Mark W El-Deiry; Amy Y Chen; Baowei Fei Journal: Clin Cancer Res Date: 2017-06-13 Impact factor: 12.531
Authors: Dongsuk Shin; Marion-Anna Protano; Alexandros D Polydorides; Sanford M Dawsey; Mark C Pierce; Michelle Kang Kim; Richard A Schwarz; Timothy Quang; Neil Parikh; Manoop S Bhutani; Fan Zhang; Guiqi Wang; Liyan Xue; Xueshan Wang; Hong Xu; Sharmila Anandasabapathy; Rebecca R Richards-Kortum Journal: Clin Gastroenterol Hepatol Date: 2014-07-25 Impact factor: 11.382
Authors: Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch Journal: Med Phys Date: 2016-06 Impact factor: 4.071
Authors: Shalini Jain; Xiao Wang; Chia-Chi Chang; Catherine Ibarra-Drendall; Hai Wang; Qingling Zhang; Samuel W Brady; Ping Li; Hong Zhao; Jessica Dobbs; Matt Kyrish; Tomasz S Tkaczyk; Adrian Ambrose; Christopher Sistrunk; Banu K Arun; Rebecca Richards-Kortum; Wei Jia; Victoria L Seewaldt; Dihua Yu Journal: Cancer Res Date: 2015-09-17 Impact factor: 12.701
Authors: Eric C Yang; Richard A Schwarz; Alexander K Lang; Nancy Bass; Hawraa Badaoui; Imran S Vohra; Katelin D Cherry; Michelle D Williams; Ann M Gillenwater; Nadarajah Vigneswaran; Rebecca R Richards-Kortum Journal: Cancer Prev Res (Phila) Date: 2018-06-14
Authors: Fangyao Hu; Karthik Vishwanath; H Wolfgang Beumer; Liana Puscas; Hamid R Afshari; Ramon M Esclamado; Richard Scher; Samuel Fisher; Justin Lo; Christine Mulvey; Nirmala Ramanujam; Walter T Lee Journal: Oral Oncol Date: 2014-07-16 Impact factor: 5.337